심볼 | 시가총액 | 가격 | 변화 % | 거래량 | 상대적 거래량 | P/E | EPS 희석 순마진 | EPS 희석 성장 TTM YoY | 배당 수익 % 순마진 | 섹터 | 애널리스트 평점 |
---|---|---|---|---|---|---|---|---|---|---|---|
LLYELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 DR | 606.74 T ARS | 14000.000 ARS | +1.06% | 217 | 0.11 | — | — | — | — | 의료 기술 | — |
LLYDELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD) DR | 606.74 T ARS | 13.200 USD | 0.00% | 14 | 0.15 | — | — | — | — | 의료 기술 | — |
DJNJ3JOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS) DR | 313.566 T ARS | 1168.000 ARS | −2.42% | 11 | 0.00 | — | — | — | — | 의료 기술 | — |
JNJJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS DR | 313.566 T ARS | 10548.000 ARS | +0.21% | 1.266 K | 0.08 | 43.43 | 242.90 ARS | +459.57% | 0.87% | 의료 기술 | — |
JNJDJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS(USD) DR | 313.566 T ARS | 10.500 USD | −2.78% | 120 | 0.15 | 37.01 | 242.90 ARS | +48.88% | 0.87% | 의료 기술 | — |
MRKMERCK & CO INC CEDEAR (5 REP 1 USD0.50) DR | 280.536 T ARS | 26984.500 ARS | +0.15% | 59 | 0.09 | — | — | — | — | 의료 기술 | — |
MRKDMERCK & CO INC CEDEAR EAC 5 RE 1 (USD) DR | 280.536 T ARS | 27.150 USD | +4.42% | 28 | 4.24 | — | — | — | — | 의료 기술 | — |
ABBVABBVIE INC CEDEAR EACH 10 REPR 1 COM DR | 259.401 T ARS | 17960.500 ARS | +0.81% | 256 | 0.12 | 22.37 | 802.79 ARS | −6.12% | 0.99% | 의료 기술 | — |
ABBVDABBVIE INC CEDEAR EA 10 REP 1 COM(USD) DR | 259.401 T ARS | 17.350 USD | −2.25% | 35 | 0.29 | 17.47 | 802.79 ARS | −77.92% | 0.99% | 의료 기술 | — |
AZNASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25 DR | 187.945 T ARS | 37309.000 ARS | +0.28% | 247 | 0.23 | 179.39 | 207.98 ARS | +257.80% | 1.14% | 의료 기술 | — |
AZNDASTRAZENECA PLC CEDEAR EA RE 0.5 ADR (USD) DR | 187.945 T ARS | 36.750 USD | −0.27% | 5 | 0.70 | 142.85 | 207.98 ARS | −15.86% | 1.14% | 의료 기술 | — |
NVSNOVARTIS AG CEDEAR EACH 4 REP 1 DR | 165.385 T ARS | 26075.500 ARS | +2.66% | 23 | 0.40 | — | — | — | — | 의료 기술 | — |
NVSDNOVARTIS AG CEDEAR EAC 4 REP 1(USD) DR | 165.385 T ARS | 24.250 USD | +4.98% | 2 | 0.34 | — | — | — | — | 의료 기술 | — |
PFEPFIZER INC CEDEAR EACH 4 REP 1 ORD USD0.05 DR | 129.393 T ARS | 6960.000 ARS | −0.33% | 1.43 K | 0.06 | — | — | — | — | 의료 기술 | — |
PFEDPFIZER INC CEDEAR 4 REP 1 ORD USD0.05(USD) DR | 129.393 T ARS | 6.930 USD | +0.43% | 345 | 0.55 | — | — | — | — | 의료 기술 | — |
AMGNAMGEN INC CEDEAR EACH 30 REP 1 DR | 127.157 T ARS | 9603.000 ARS | −0.07% | 91 | 0.08 | — | — | — | — | 의료 기술 | — |
AMGNDAMGEN INC CEDEAR EACH 30REPR 1 ORD USD0.0001 (USD) DR | 127.157 T ARS | 9.750 USD | +3.72% | 72 | 1.40 | — | — | — | — | 의료 기술 | — |
BMYBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 DR | 86.907 T ARS | 17424.500 ARS | +0.31% | 22 | 0.06 | — | — | — | — | 의료 기술 | — |
BMYDBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 DR | 86.907 T ARS | 17.000 USD | −2.86% | 6 | 1.20 | — | — | — | — | 의료 기술 | — |
GSKGSK PLC CEDEAR EACH REPR 1/4 ADR DR | 72.812 T ARS | 10802.000 ARS | +0.41% | 79 | 0.36 | 55.59 | 194.30 ARS | −31.41% | 1.38% | 의료 기술 | — |
GSKDGSK PLC CEDEAR EACH REPR 1/4 ADR (USD) DR | 72.812 T ARS | 10.300 USD | +0.98% | 7 | 0.24 | 42.85 | 194.30 ARS | −83.87% | 1.38% | 의료 기술 | — |
BIIBBIOGEN INC CEDEAR EACH 13 REP 1 COM USD0.0005 DR | 24.621 T ARS | 15900.000 ARS | +0.61% | 4 | 0.01 | — | — | — | — | 의료 기술 | — |
BIIBDBIOGEN INC CEDEAR EAC 13 RE 1 COM(USD) DR | 24.621 T ARS | 16.250 USD | −18.75% | 20 | 2.47 | — | — | — | — | 의료 기술 | — |
RICHLABORATORIOS RICHMOND SACIF | 71.102 B ARS | 899.000 ARS | +2.10% | 130 | 0.02 | — | −130.78 ARS | — | 0.00% | 의료 기술 | — |
ROSEINSTITUTO ROSENBUCH SA DE BIOLOGIA | 3.901 B ARS | 91.600 ARS | −6.05% | 8.714 K | 1.34 | — | — | — | 0.00% | 의료 기술 | — |